摘要
目的研究依达拉奉对急性脑梗死患者C反应蛋白的影响及和预后的关系。方法将78例急性脑梗死患者随机分两组,每组均为39例,均使用基础治疗,治疗组加用依达拉奉。治疗15d后比较两组患者的C反应蛋白变化和NDS评分。结果急性脑梗死患者血清C反应蛋白水平增高,依达拉奉治疗15d后血清C反应蛋白水平明显降低,NDS评分改善,与对照组相比有显著性差异。结论依达拉奉能够显著降低急性脑梗死患者血清C反应蛋白水平,进而改善急性脑梗死患者神经功能缺失,对急性脑梗死患者预后具有重要意义。
Objective To study the effects of Edaravone on C-reactive protein ot patients w^ttt acute cereorat miarcHon and its relationship with prognosis. Methods Seventy-eight patients with acute cerebral infarction were randomly divided into two groups, with 39 cases in each group. Both groups were taken foundation treatment, and the treatment group was added with Edaravone. After treatment for 15 days, the C-reactive protein changes and NDS scores of patients between the two groups were compared. Results The level of serum C-reactive protein of patients with acute cerebral infarction was in- creased. After treatment of Edaravone for 15 days, the level of serum C-reactive protein was decreased obviously and NDS scores were improved, there were significant differences compared with control group. Conclusion Edaravone can significantly reduce the level of serum C-reactive protein of patients with acute cerebral infarction, and improve the neurological deficit sts of patients with acute cerebral infarction. It is of great importance in the prognosis of patients with acute cerebral infarction.
出处
《中国当代医药》
2012年第18期25-26,28,共3页
China Modern Medicine
关键词
依达拉奉
C反应蛋白
急性脑梗死
自由基清除剂
Edaravone
C-reactive protein
Acute cerebral infarction
Free radical scavenger
